CONMED Corporation Reports Second Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
Wednesday, July 29, 2026 1 min read
Key Takeaway: CONMED Corporation reported its financial results for the second quarter of 2026, showing a slight increase in sales compared to the previous year. The company also provided an updated financial guidance for the full year, indicating a positive outlook. Notably, organic net sales rose by 6.0% after excluding the impact of strategic exits from GI product offerings.
Market Sentiment Analysis
POSITIVE FACTORS
Sales increased by 0.3% year-over-year.
Net sales grew by 6.0% on an organic constant currency basis.
The company updated its financial guidance positively for 2026.
Full Press Release Details
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today reported financial results for the second quarter ended June 30, 2026 and updated its financial guidance for the full year ending 2026. Second Quarter 2026 Highlights(1) Sales of $343.5 million increased 0.3% year-over-year as reported and decreased 0.5% on a constant currency(2) basis. Excluding the impact of the Company’s previously announced strategic exits of GI product offerings, net sales increased 6.0% on an organic cons
Frequently Asked Questions
What were CONMED's sales for Q2 2026?
CONMED reported sales of $343.5 million for the second quarter of 2026.
How did sales change year-over-year?
Sales increased by 0.3% year-over-year.
What is the organic sales growth for CONMED?
Excluding strategic exits, organic net sales increased by 6.0%.
Did CONMED update its financial guidance?
Yes, CONMED updated its financial guidance for the full year 2026.